Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts. Show more

Location: 11 Huron Drive, Natick, MA, 01760, United States | Website: https://www.allurion.com | Industry: Medical Devices | Sector: Healthcare


Market Cap

15.91M

52 Wk Range

$1.93 - $20.00

Previous Close

$2.05

Open

$2.05

Volume

66,714

Day Range

$2.00 - $2.09

Enterprise Value

33.87M

Cash

12.72M

Avg Qtr Burn

-10.45M

Insider Ownership

10.26%

Institutional Own.

40.98%

Qtr Updated

06/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date